ArticleThoracic cancer2022

Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy.

Yufan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.